May. 6 at 12:42 PM
$ESTA
Establishment Labs (NASDAQ: ESTA)
Buy (1)
ESG Score: 48/100
Price Target:
$95.00
ESTA 1Q Beat and Raise Breaks the Discouraging MedTech Trend; Reiterate Buy
THE TD COWEN INSIGHT
1Q revenues of
$59.9M came in ~4% higher vs. the Street, and ESTA raised 2026 revenue guidance by roughly the beat. Encouragingly, U.S. Motiva drove most of the outperformance, and ESTA raised 2026 revenue expectations for both the U.S. and WW minimally invasive franchises. Finally, the company remained Adj. EBITDA positive in 1Q, a trend that management expects to continue throughout the year.
